Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients
Authors:
- Stefano TaddeiSTStefano Taddei
- Agostino VirdisAVAgostino Virdis
- Lorenzo GhiadoniLGLorenzo Ghiadoni
- Paola MatteiPMPaola Mattei
- Antonio SalvettiASAntonio Salvetti
- 1 April 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 16 (4) , 447-456
Abstract
Essential hypertension is characterized by an impairment of endothelium-dependent vasodilatation. To test whether antihypertensive treatment with the angiotensin converting enzyme inhibitor lisinopril can improve vasodilatation in response to endothelium-dependent agonists in essential hypertensive patients. We studied the effect of acute (6–8 h after dosing), prolonged (1 month) and chronic (12 months) lisinopril treatment on forearm blood flow response (strain-gauge plethysmography) induced in 10 hypertensive patients (aged 43.6 ± 8.1 years, blood pressure 151.4 ± 6.8/99.8 ± 3.3 mmHg) by intrabrachial infusions of 0.15, 0.45, 1.5, 4.5, and 15 μg/100 ml per min acetylcholine and 5, 15, and 50 ng/100 ml per min bradykinin, two endothelium-dependent vasodilators, and 1, 2, and 4 μg/100 ml per min sodium nitroprusside, an endothelium-independent vasodilator. At baseline, vascular response was compared with that of 10 normotensive subjects (aged 42.4 ± 6.6 years, blood pressure 118.4 ± 6.1/77.8 ± 3.4 mmHg). Hypertensive patients had blunted (P < 0.01 or less) vasodilatations in response to infusions of acetylcholine (from 3.7 ± 0.3 to 18.3 ± 4.9 ml/100 ml per min) and bradykinin (from 3.7 ± 0.4 to 15.8 ± 2.6 ml/100 ml per min) compared with those of controls (from 3.6 ± 0.3 to 25.3 ± 5.2 ml/100 ml per min for acetylcholine and from 3.7 ± 0.3 to 26.9 ± 4.9 ml/100 ml per min for bradykinin) whereas the responses to infusion of sodium nitroprusside were similar (from 3.6 ± 0.3 to 18.5 ± 3.9 and from 3.6 ± 0.3 to 16.4 ± 1.8 ml/100 ml per min, respectively). Acute and prolonged lisinopril treatments significantly (P < 0.05 or less) improved vasodilatation in response to infusion of bradykinin (from 3.7 ± 0.4 to 24.5 ± 4.9 and from 3.7 ± 0.3 to 22.1 ± 4.9 ml/100 ml per min, respectively), but not in response to infusions of acetylcholine and of sodium nitroprusside. Chronic lisinopril treatment increased (P < 0.05) the response to infusions of not only bradykinin (from 3.5 ± 0.5 to 27.6 ± 5.3 ml/100 ml per min), but also of acetylcholine (from 3.5 ± 0.5 to 27.8 ± 8.0 ml/100 ml per min) and sodium nitroprusside (from 3.4 ± 0.6 to 25.9 ± 8.5 ml/100 ml per min). However, when the responses to infusions of acetylcholine and bradykinin were normalized with respect to that to infusion of sodium nitroprusside, only the vasodilatation in response to infusion of bradykinin was shown to have been increased by lisinopril treatment. Administration of lisinopril to patients with essential hypertension can selectively increase vasodilatation in response to infusion of bradykinin.Keywords
This publication has 45 references indexed in Scilit:
- Effect of Insulin on Acetylcholine-Induced Vasodilation in Normotensive Subjects and Patients With Essential HypertensionCirculation, 1995
- Aging and Endothelial Function in Normotensive Subjects and Patients With Essential HypertensionCirculation, 1995
- Vasodilation to acetylcholine in primary and secondary forms of human hypertension.Hypertension, 1993
- Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.Circulation, 1993
- Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension.Circulation, 1993
- Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential HypertensionNew England Journal of Medicine, 1990
- Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension.Circulation, 1990
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980